Umbilical cord mesenchymal stem cell (UC-MSC) transplantations for cerebral palsy

Area of Science:

• Neurology
• Regenerative Medicine
• Pediatrics

Background:

• Cerebral palsy (CP) presents with motor deficits, abnormal muscle tone, and gait instability.
• Electroencephalogram (EEG) abnormalities and seizures are common in pediatric CP cases.
• Current CP treatments focus on managing symptoms and improving quality of life.

Observation:

• A 4-year-old boy diagnosed with cerebral palsy exhibited motor skill impairments, abnormal muscle tone, and frequent falls.
• The patient presented with moderately abnormal EEG results and irregular seizures.
• Umbilical cord mesenchymal stem cell (UC-MSC) transplantation was administered three times.

Findings:

• Following UC-MSC transplantation, the patient demonstrated significant improvements in EEG readings, limb strength, and motor function.
• Enhanced language expression was observed post-treatment.
• While physical and neurological symptoms improved, the patient's intelligence quotient (IQ) showed less significant advancement.

Implications:

• UC-MSC transplantation represents a potentially effective therapeutic strategy for improving neurological and motor outcomes in children with cerebral palsy.
• Further research is warranted to optimize UC-MSC therapy and assess its long-term effects on cognitive function in CP patients.
• This case highlights the potential of stem cell therapy in addressing complex neurological disorders like CP.